E Cubo Delgado, N Mariscal-Pérez, B Solano, V Becerra, J Arribas 67th Annual Meeting of the American Academy of Neurology, Washington, DC, 2015
Blog Archives
Continuous Motion Sensor Assessment of Parkinson’s Disease During Activities of Daily Living
C Pulliam, D Heldman, E Brokaw, M Burack, T Mera 67th Annual Meeting of the American Academy of Neurology, Washington, DC, 2015
Wearables and Apps for Parkinson’s disease: Why Big Data and Big Names May Not Be Small Enough
VIEW PRESS RELEASE PDF 17 MAR 2015: Cleveland, OH – While headlines recently surged over big organizations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for…
PRESS RELEASE: Great Lakes NeuroTech Pilot Studies Demonstrate Computer Guided Algorithms for Programming Deep Brain Stimulation in Parkinson’s Disease
VIEW PRESS RELEASE PDF 06 FEB 2015: Valley View, OH – Great Lakes NeuroTechnologies announced today they have completed two pilot studies [ http://glneurotech.com/kinesia/validation/dbs-pilot-study/ ] demonstrating computer-guided algorithms for programming deep brain stimulation (DBS) in Parkinson’s disease. The first study,…
PRESS RELEASE: Great Lakes NeuroTech Enters Medical Device App Market with Kinesia One for Monitoring Parkinson’s Disease
VIEW PRESS RELEASE 12 NOV 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have successfully transitioned their Kinesia technology for objective monitoring of Parkinson’s disease to an app platform. Kinesia ONE™ [http://glneurotech.com/kinesia/] uses a patient worn sensor…
PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps
VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with…
Tagged with: app, dbs, deep brain stimulation, fda, kinesia, mobile, nih, parkinson's disease, parkinson's telemedicine, remote, rigidity, sensor, telemedicine, therapy, tremor
PRESS RELEASE: GLNT Secures Allowance Of Patent For Controlling Parkinson’s Therapy In Response To Symptoms
VIEW PRESS RELEASE [PDF] 04 FEB 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson’s therapy in…
PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities
VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor…
PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by…
PRESS RELEASE: Kinesia ProView Launches to Visualize Parkinson’s Symptom Response to Deep Brain Stimulation Programming
VIEW PRESS RELEASE [PDF] 15 MAY 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today the product launch of Kinesia ProView™ [ http://www.glneurotech.com/kinesia/proview/index.php ] to visualize motor symptom severity response during programming of deep brain stimulation (DBS) for Parkinson’s…